Atrial Fibrillation, Type 2 Diabetes
Conditions
Brief summary
This case-control study was conducted at Burapha University Hospital. The 12-lead electrocardiography recordings of type 2 diabetes patients were reviewed by a cardiologist to confirm the presence of atrial fibrillation. The clinical parameters, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications were analyzed and compared between atrial fibrillation and non-atrial fibrillation patients.
Interventions
OTHERRoutine examinations
Electrocardiography and clinical parameters examinations, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications
Sponsors
Burapha University
Study design
Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Outpatients with type 2 diabetes who visited the medical clinic between June 2022 and June 2023
Exclusion criteria
* Patients with missing information on the urinary albumin value and electrocardiograms at the latest date
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of atrial fibrillation | June 2022 and June 2023 | Prevalence of atrial fibrillation in patients with type 2 diabetes |
| Factors associated with atrial fibrillation | June 2022 and June 2023 | Factors associated with atrial fibrillation in patients with type 2 diabetes, including age, hypertension, heart failure, thyroid disease, type 2 diabetes duration, body mass index, estimated glomerular filtration rate, glycated hemoglobin, presence of albuminuria, and use of diuretic medications |
Countries
Thailand
Outcome results
None listed